drugset / Trial / NCT02449889

A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

NCT02449889

Phase 3 Completed 176 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blindTreatment

Summary

This trial is investigating the efficacy and safety of highly purified human chorionic gonadotropin (HP-hCG) and recombinant human chorionic gonadotropin (rhCG) for triggering of final follicular maturation in women undergoing controlled ovarian stimulation

Timeline

Start
2016-04
Primary completion
2017-07-09
Completion
2018-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ovidrel Protein / enzyme biologic
Subject highly purified human chorionic gonadotropin Unknown Intramuscular

Indications